Ivax Glucophage XR Generic Exclusivity Extended; New Twist On “Late-List”
Executive Summary
Ivax will gain at least an additional 30 days of generic marketing exclusivity for Bristol-Myers Squibb's Glucophage XR after a federal judge issued a temporary restraining order blocking FDA from approving other metformin extended-release ANDAs